Sahajanand Medical Technologies
Issue -
Market attention score 23 (how ranked)
IPO alerts
Get notified for open, close, allotment. Delivered in-app, push, and email.
Automated WhatsApp broadcasts aren't available yet — use this to ping yourself or a group.
Opens
15 Oct 2026
Closes
19 Oct 2026
Allotment
21 Oct 2026
Listing
23 Oct 2026
Overview
Sahajanand Medical Technologies IPO is a book build issue of 2.76 crore shares. The issue is entirely an offer for sale of 2.76 crore shares.
Sahajanand Medical Technologies IPO opens for subscription on Oct 15, 2026 and closes on Oct 19, 2026. The allotment for the Sahajanand Medical Technologies IPO is expected to be finalized on Oct 21, 2026. Sahajanand Medical Technologies IPO will list on NSE and BSE with a tentative listing date fixed as Oct 23, 2026.
Sahajanand Medical Technologies IPO is set issue price band at [.] to [.] per share.
Motilal Oswal Investment Advisors Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Sahajanand Medical Technologies IPO RHP for detailed Information.
Issue details
IPO Date
15 to 19 Oct, 2026
Listing Date
Fri, Oct 23, 2026
Face Value
₹1 per share
Sale Type
OFS only
Issue Type
Bookbuilding IPO
Listing At
BSE, NSE
Issue reservation
| Investor Category | Shares |
|---|---|
| QIB | Not more than 50% of the Net Offer |
| Retail | Not less than 35% of the Net Offer |
| NII | Not less than 15% of the Net Offer |
About the company
Founded in 2001 by Mr. Dhirajlal Kotadia, Sahajanand Medical Technologies Ltd. is a medical device company focused on Class III and Class C/D devices, primarily in the fields of vascular and structural heart intervention. The company was the first globally to receive CE certification for a drug-eluting stent (DES) with a biodegradable polymer—Infinnium.
Sahajanand operates two R&D centers—one in India and one in Thailand—supported by a team of 102 professionals, including biomedical engineers and clinical research specialists. The company has built a robust intellectual property base, with 102 patents granted globally and 71 pending patent applications, along with five design registrations in India.
Key products such as Supraflex Cruz (DES) , Hydra (TAVI) , and Cocoon (Occluders) are backed by 72 clinical studies, and are widely accepted in over 76 countries across Europe, Asia, and other regions. The global distribution strategy includes direct operations in key European markets (Germany, Spain, France, UK), hybrid models in India (serving hospitals like Narayana Hrudayalaya Limited), and distributor-led entry in markets such as Italy.
International market adoption is reinforced by endorsements from key opinion leaders (KOLs), successful government tenders, and partnerships with major Group Purchasing Organizations (GPOs) in Europe.
The company follows a “House of Brand” strategy, developing and commercializing clinically differentiated products under recognized brand names like Supraflex Cruz, Hydra, and Cocoon.
As of March 31, 2025, Sahajanand Medical Technologies employed 1,458 full-time staff, 24 consultants, and 818 contract-based personnel across its operations.
Financials
| Metric | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 1,309.00 | 1,276.43 | 1,094.90 | 970.58 |
| Total Income | 354.33 | 1,218.73 | 1,035.96 | 908.59 |
| Profit After Tax | 15.09 | 69.08 | 25.15 | -7.35 |
| EBITDA | 48.58 | 170.66 | 128.02 | 110.05 |
| NET Worth | 631.72 | 616.05 | 545.23 | 526.30 |
| Reserves and Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
| Total Borrowing | 320.63 | 269.53 | 224.96 | 175.27 |
Amounts in ₹ Crore (restated)
Key performance indicators
| KPI | Jun 30, 2026 | Mar 31, 2026 |
|---|---|---|
| ROE | 2.07% | 10.35% |
| ROCE | 3.16% | 11.57% |
| Debt/Equity | 0.33 | 0.27 |
| RoNW | 2.31% | 10.60% |
| PAT Margin | 4.29% | 5.71% |
| EBITDA Margin | 13.81% | 14.10% |
| NAV | 64.35 | 62.76 |
Valuation
Valuation Metric
Pre IPO
EPS (₹)
6.80
Objects of the issue
- ROE — 2.07%
- ROCE — 3.16%
- Debt/Equity — 0.33
- RoNW — 2.31%
- PAT Margin — 4.29%
- EBITDA Margin — 13.81%
- NAV — 64.35
Intermediaries
Registrar
MUFG Intime India Pvt.Ltd.
Lead manager(s)
Motilal Oswal Investment Advisors Ltd., Avendus Capital Pvt.Ltd., HSBC Securities & Capital Markets (India) Pvt.Ltd., Nuvama Wealth Management Ltd.
FAQs
How to apply in Sahajanand Medical Technologies IPO through Zerodha?+
Zerodha customers can apply online in Sahajanand Medical Technologies IPO using UPI as a payment gateway. Zerodha customers can apply in Sahajanand Medical Technologies IPO by login into Zerodha Console (back office) and submitting an IPO application form. Steps to apply in Sahajanand Medical Technologies IPO through Zerodha Visit the Zerodha website and login to Console. Go to Portfolio and click the IPOs link. Go to the ' Sahajanand Medical Technologies IPO ' row and click the 'Bid' button. Enter your UPI ID, Quantity, and Price. Submit IPO application form. Visit the UPI App (net banking or BHIM ) to approve the mandate. Visit Zerodha IPO Application Process Review for more detail.
When Sahajanand Medical Technologies IPO will open?+
The Sahajanand Medical Technologies IPO opens on Thu, Oct 15, 2026 and closes on Mon, Oct 19, 2026.
What is the lot size of Sahajanand Medical Technologies IPO?+
Sahajanand Medical Technologies IPO lot size and the minimum order quantity is not available at this time. Please check again later.
How to apply for Sahajanand Medical Technologies IPO?+
You can apply in Sahajanand Medical Technologies IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha , Upstox , 5Paisa , Nuvama , HDFC Bank , and SBI Bank .
When is Sahajanand Medical Technologies IPO allotment?+
The finalization of Basis of Allotment for Sahajanand Medical Technologies IPO will be done on Wednesday, October 21, 2026 , and the allotted shares will be credited to your demat account by Thu, Oct 22, 2026 . Check the Sahajanand Medical Technologies IPO allotment status .
When is Sahajanand Medical Technologies IPO listing date ?+
The Sahajanand Medical Technologies IPO listing date is not yet announced. The tentative date of listing is Fri, Oct 23, 2026 .
Aggregated from public IPO filings. GMP is unofficial grey-market chatter, not advice.